140 related articles for article (PubMed ID: 22668871)
1. Role of CSN5/JAB1 in Wnt/β-catenin activation in colorectal cancer cells.
Schütz AK; Hennes T; Jumpertz S; Fuchs S; Bernhagen J
FEBS Lett; 2012 Jun; 586(11):1645-51. PubMed ID: 22668871
[TBL] [Abstract][Full Text] [Related]
2. The β-catenin E3 ubiquitin ligase SIAH-1 is regulated by CSN5/JAB1 in CRC cells.
Jumpertz S; Hennes T; Asare Y; Vervoorts J; Bernhagen J; Schütz AK
Cell Signal; 2014 Sep; 26(9):2051-9. PubMed ID: 24882689
[TBL] [Abstract][Full Text] [Related]
3. CSN5/JAB1 suppresses the WNT inhibitor DKK1 in colorectal cancer cells.
Jumpertz S; Hennes T; Asare Y; Schütz AK; Bernhagen J
Cell Signal; 2017 Jun; 34():38-46. PubMed ID: 28229932
[TBL] [Abstract][Full Text] [Related]
4. CSN5/Jab1 controls multiple events in the mammalian cell cycle.
Yoshida A; Yoneda-Kato N; Panattoni M; Pardi R; Kato JY
FEBS Lett; 2010 Nov; 584(22):4545-52. PubMed ID: 20974137
[TBL] [Abstract][Full Text] [Related]
5. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
6. HER-2/neu transcriptionally activates Jab1 expression via the AKT/beta-catenin pathway in breast cancer cells.
Hsu MC; Chang HC; Hung WC
Endocr Relat Cancer; 2007 Sep; 14(3):655-67. PubMed ID: 17914096
[TBL] [Abstract][Full Text] [Related]
7. Jab1 promotes glioma cell proliferation by regulating Siah1/β-catenin pathway.
Zhu Y; Qiu Z; Zhang X; Qian F; Wang B; Wang L; Shi H; Yu R
J Neurooncol; 2017 Jan; 131(1):31-39. PubMed ID: 27640199
[TBL] [Abstract][Full Text] [Related]
8. CSN5 silencing inhibits invasion and arrests cell cycle progression in human colorectal cancer SW480 and LS174T cells in vitro.
Zhong G; Li H; Shan T; Zhang N
Int J Clin Exp Pathol; 2015; 8(3):2809-15. PubMed ID: 26045788
[TBL] [Abstract][Full Text] [Related]
9. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity.
Lue H; Kapurniotu A; Fingerle-Rowson G; Roger T; Leng L; Thiele M; Calandra T; Bucala R; Bernhagen J
Cell Signal; 2006 May; 18(5):688-703. PubMed ID: 16122907
[TBL] [Abstract][Full Text] [Related]
10. The COP9 signalosome mediates beta-catenin degradation by deneddylation and blocks adenomatous polyposis coli destruction via USP15.
Huang X; Langelotz C; Hetfeld-Pechoc BK; Schwenk W; Dubiel W
J Mol Biol; 2009 Aug; 391(4):691-702. PubMed ID: 19576224
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the role of COP9 Signalosome (CSN) subunits in K562; the first link between CSN and autophagy.
Pearce C; Hayden RE; Bunce CM; Khanim FL
BMC Cell Biol; 2009 Apr; 10():31. PubMed ID: 19400951
[TBL] [Abstract][Full Text] [Related]
12. CSN5 Promotes Hepatocellular Carcinoma Progression by SCARA5 Inhibition Through Suppressing β-Catenin Ubiquitination.
Liu H; Hu J; Pan H; Luo D; Huang M; Xu W
Dig Dis Sci; 2018 Jan; 63(1):155-165. PubMed ID: 29189991
[TBL] [Abstract][Full Text] [Related]
13. CSN5/Jab1 facilitates non-small cell lung cancer cell growth through stabilizing survivin.
Li J; Li Y; Wang B; Ma Y; Chen P
Biochem Biophys Res Commun; 2018 Jun; 500(2):132-138. PubMed ID: 29596838
[TBL] [Abstract][Full Text] [Related]
14. Suppression of CSN5 promotes the apoptosis of gastric cancer cells through regulating p53-related apoptotic pathways.
Sang MM; Du WQ; Zhang RY; Zheng JN; Pei DS
Bioorg Med Chem Lett; 2015 Aug; 25(15):2897-901. PubMed ID: 26048783
[TBL] [Abstract][Full Text] [Related]
15. Stat3 contributes to cancer progression by regulating Jab1/Csn5 expression.
Pan Y; Wang S; Su B; Zhou F; Zhang R; Xu T; Zhang R; Leventaki V; Drakos E; Liu W; Claret FX
Oncogene; 2017 Feb; 36(8):1069-1079. PubMed ID: 27524414
[TBL] [Abstract][Full Text] [Related]
16. CSN5/Jab1 inhibits cardiac L-type Ca2+ channel activity through protein-protein interactions.
Kameda K; Fukao M; Kobayashi T; Tsutsuura M; Nagashima M; Yamada Y; Yamashita T; Tohse N
J Mol Cell Cardiol; 2006 Apr; 40(4):562-9. PubMed ID: 16483597
[TBL] [Abstract][Full Text] [Related]
17. The emerging roles of Jab1/CSN5 in cancer.
Wang L; Zheng JN; Pei DS
Med Oncol; 2016 Aug; 33(8):90. PubMed ID: 27412572
[TBL] [Abstract][Full Text] [Related]
18. Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging.
Yeh CT; Rao YK; Ye M; Wu WS; Chang TC; Wang LS; Wu CH; Wu AT; Tzeng YM
Toxicol Appl Pharmacol; 2012 May; 261(1):31-41. PubMed ID: 22465936
[TBL] [Abstract][Full Text] [Related]
19. Depletion of CSN5 inhibits Ras-mediated tumorigenesis by inducing premature senescence in p53-null cells.
Tsujimoto I; Yoshida A; Yoneda-Kato N; Kato JY
FEBS Lett; 2012 Dec; 586(24):4326-31. PubMed ID: 23127558
[TBL] [Abstract][Full Text] [Related]
20. Targeted silencing of Jab1/Csn5 in human cells downregulates SCF activity through reduction of F-box protein levels.
Cope GA; Deshaies RJ
BMC Biochem; 2006 Jan; 7():1. PubMed ID: 16401342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
